Form 4 for IMDX Insight Molecular Diagnostics Inc.
Accepted 2024-12-27 00:00:00 ET · period of report 2024-12-26 · accession 0001493152-24-052334 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-12-27 | 2024-12-26 | IMDX | SMITH PATRICK W | 10% | P - Purchase | $2.13 | +90.2K | 1.77M | +5% | +$192.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, no par value | 2024-12-26 | P | A | 90,219 | $2.13 | 1,773,903 | I See footnote | — | — | (F1) The shares of common stock reported herein are directly held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust. |